Clinical Trial Update: MLC901 for Moderate to Severe Traumatic Brain Injury (Specified Drug Code) [Phase 4]

View source ↗

Summary

Clinical trial update for MLC901 in moderate to severe traumatic brain injury (Phase 4) with unspecified status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• MLC901

Snippet

Sponsor: Ali Amini Harandi | Conditions: Traumatic Brain Injury | Phase 4 | Status: UNKNOWN